Notice Type
Departmental
Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto: Schedule Product: Neurontin. Active Ingredient(s): Gabapentin 100 mg. Dosage Form: Capsule. NZ Sponsor: Parke Davis (Div. Warner Lambert NZ Limited). Manufacturer(s): Godecke AG, Freiburg, Germany. Product: Neurontin. Active Ingredient(s): Gabapentin 300 mg. Dosage Form: Capsule. NZ Sponsor: Parke Davis (Div. Warner Lambert NZ Limited). Manufacturer(s): Godecke AG, Freiburg, Germany. Product: Neurontin. Active Ingredient(s): Gabapentin 400 mg. Dosage Form: Capsule. NZ Sponsor: Parke Davis (Div. Warner Lambert NZ Limited). Manufacturer(s): Godecke AG, Freiburg, Germany. Dated this 7th day of October 1999. S. S. JESSAMINE, Acting Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
Publication Date
14 Oct 1999

Notice Number

1999-go7516

Page Number

3582